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Objectives This study sought to examine the relationship between inflammation and coronary microvascular function in
asymptomatic individuals using positron emission tomography (PET) and assessment of coronary flow reserve
(CFR).
Background Coronary microvascular dysfunction is an early precursor of coronary artery disease (CAD) thought to result from
endothelial cell activation and inflammation, but data are limited.
Methods We examined 268 asymptomatic male monozygotic and dizygotic twins. Plasma biomarkers of inflammation
and endothelial cell activation included C-reactive protein (CRP), interleukin (IL)-6, white blood cell count (WBC),
vascular cell adhesion molecule (VCAM)-1, and intercellular adhesion molecule (ICAM)-1. Blood flow quantitation
was obtained with [13N] ammonia PET at rest and after adenosine stress. CFR was measured as the ratio of
maximum flow to baseline flow at rest; abnormal CFR was defined as a ratio 2.5. A summed stress score for
visible perfusion defects was calculated.
Results In within-pair analyses, all biomarkers, except VCAM-1, were higher in twins with lower CFR than their brothers
with higher CFR (p  0.05). This was observed in the entire sample, as well as within pairs discordant for a CFR
of 2.5. Associations persisted after adjusting for summed stress score and CAD risk factors. In contrast no bio-
marker, except IL-6, was related to the summed stress score of visible defects.
Conclusions Even in asymptomatic subjects, a decrease in coronary microvascular function is accompanied by a systemic
inflammatory response, independent of CAD risk factors. Our results, using a controlled twin design, highlight
the importance of coronary microvascular function in the early phases of CAD. (J Am Coll Cardiol 2011;57:
1271–9) © 2011 by the American College of Cardiology FoundationCoronary microvascular dysfunction refers to abnormal
regulation of the coronary microcirculation resulting in
reduced myocardial blood flow with increased demand that
is not explained by disease in the epicardial coronary arteries
(1). It is thought to result from vasomotor dysregulation or
endothelial dysfunction of the small coronary arterioles and
represents 1 of the earliest signs of coronary atherosclerosis
(1,2). Although no technique enables the direct visualization
of the coronary microcirculation in humans in vivo, in the
absence of coronary artery disease (CAD), coronary microvas-
cular disease manifests as impaired coronary flow reserve
(CFR), an index of coronary vasodilator capacity (2,3).
Among individuals without evidence of CAD and myo-
cardial disease, coronary microvascular dysfunction is typi-
cally attributed to traditional coronary risk factors (smoking,
hypertension, hyperlipidemia, and diabetes and insulin-
resistant states), but the underlying pathophysiology is
unclear (1,4). Functional abnormalities of the microcircula-
tion have been proposed, including endothelial and/or
vascular smooth muscle cell dysfunction, as well as extravas-
cular influences, such as autonomic dysfunction (4). Vascu-
lar inflammation and endothelial cell activation have been
suggested as plausible pathophysiological mechanisms, since
they have also been linked to vascular function in the
periphery (5,6). For the coronary circulation, however, data
in humans are limited and inconsistent (7,8). Part of the
difficulties are due to the selected patient samples that have
been evaluated using invasive angiographic methods and
Doppler technology. Whether a relationship between in-flammation and CFR exists in asymptomatic individuals is
fundamentally unexplored.
The purpose of our study was to examine the relationship
between inflammation and CFR in a controlled study of
asymptomatic middle-aged male twins. CFR, measured by
positron emission tomography (PET), is currently the most
established noninvasive method of assessing microvascular
function, and can be used in asymptomatic subjects (2,3).
Because inflammation is a key mechanism through which
several risk factors increase CAD risk (9), and a reduced
CFR has been linked to CAD risk factors (10–15) and with
adverse long-term prognosis (16,17), we were interested in
examining whether the relationship between inflammation
and CFR was independent of CAD risk factors. Twins
provide unique opportunities to study the association be-
tween inflammation and CFR while controlling for shared
environmental or genetic factors, because twin siblings share
genes (50%, on average, if dizygotic, and all if monozy-
gotic), maternal factors, and early familial environment.
Methods
Subjects. The THS (Twins Heart Study) is an investiga-
tion of psychological, behavioral, and biological risk factors
for subclinical cardiovascular disease using twins (18,19).
Twins were selected from the VET (Vietnam Era Twin)
Registry (20), which includes 7,369 middle-aged male–male
twin pairs, both of whom served in the U.S. military during the
time of the Vietnam War. THS included 180 twin pairs, 93
monozygotic and 87 dizygotic, who were born between 1946
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March 15, 2011:1271–9 Inflammation and Coronary Flow Reserveand 1956. Zygosity information was determined by DNA
typing. Two groups of twin pairs were randomly sampled from
the VET Registry: 1 group included twins discordant for a
lifetime history of major depression, and in a second group,
neither twin had a history of depression. All twins were
examined at the Emory University General Clinical Research
Center between March 2002 and March 2006; their medical
history was updated at the examination. The protocol was
approved by the Institutional Review Board at Emory Univer-
sity, and informed consent was obtained from all subjects.
PET protocol. Subjects underwent imaging of myocardial
blood flow (MBF) with PET nitrogen 13 [13N] ammonia at
rest and following pharmacological (adenosine) stress dur-
ing a single imaging session. All twins were admitted to the
GCRC in the late morning or early afternoon on the day
prior to the PET scan, and stayed overnight in the GCRC
facility. They all received a similar low-fat dinner, and then
remained fasting until the PET scan was completed the
following morning. They were instructed to abstain from
smoking and drinking alcoholic or caffeinated beverages and
from eating any foods other than what was served to them. All
medications were withheld the morning of the PET scan. The
imaging protocol was performed by personnel unaware of the
twins’ medical history or other subject characteristics.
PET scanning was performed in 2-dimensional mode
using a CTI ECAT Exact 47 (921) camera (5-mm resolu-
tion) (Siemens, Knoxville, Tennessee). Initially, a 2- to
3-mCi dose of [13N] ammonia was injected, and a 4-min
tatic scan was collected and reconstructed without any
orrections to verify subject position. Then, rest and phar-
acological stress (adenosine) ammonia imaging was per-
ormed. The rest and stress imaging protocols were identical
xcept that a 4-min infusion of adenosine (0.14 mg/kg/min)
as started 2 min prior to the ammonia injection for the
tress imaging session. 20 mCi of [13N]ammonia were
njected, and a 5-min, 31-frame dynamic acquisition was
tarted (12 frames  5 s, 3 frames  20 s, and 1 frame 
00 s). Data were collected in 47 planes 3.375-mm thick
overing a range of 16 cm. Immediately after the conclusion
f the dynamic sequence, a 15-min gated acquisition was
tarted. Finally, transmission data were collected for 5 min
n the windowed mode using germanium 68 (68Ge) rods for
segmented attenuation correction. The process was re-
peated, including a second transmission scan, for the stress
study. Images were reconstructed with filtered back projec-
tion using a Hann filter cutoff at 1 cycle/cm. The electro-
cardiogram was monitored continuously, and blood pressure
and heart rate measurements were taken before, during
(every minute), and after the adenosine infusion. The
rate-pressure product was calculated as the mean systolic
blood pressure during adenosine infusion multiplied by the
mean heart rate during adenosine infusion divided by 100.
PET flow measures. To calculate CFR, measurements
of MBF at rest and during adenosine hyperemia were
obtained. The last frame of the dynamic sequence was
used as a template for sectorial region-of-interest analy- wsis. The input function was
generated by drawing a region
of interest in the left ventricular
chamber on a mid-ventricular
slice, and flow was calculated
(expressed in milliliters per
minute per gram of tissue) us-
ing established methodology
(21,22). The left ventricle was
sampled radially from 40 differ-
ent angles, and 40 samples of
flow were obtained for each
short-axis slice. The resulting
hundreds of samples were grouped
into 20 segments.
Our main outcome was the
overall measure of CFR for the
entire myocardium (across all 20
regions), defined as the ratio of
maximum flow during stress to
flow at rest. Secondarily, regional CFR was also calculated
(i.e., left anterior descending, left circumflex, and right
coronary artery territory). Absolute increase in hyperemic
blood flow, calculated as the difference between maximum
flow during stress and flow at rest, was also examined.
Myocardial perfusion defect score. In addition to flow
measures, we constructed a summation score describing the
number and the severity of visible perfusion defects across the
20 segments of acquisition. In each segment, the defect severity
was quantified on a 4-point scale and subsequently summed up
across the 20 segments, yielding a total score. Separate scores
were obtained for the rest (summed rest score) and stress
(summed stress score) scans. A reversible defect score (summed
difference score) was obtained by subtracting the rest score
from the stress score. These scores, and a dichotomous indi-
cator of perfusion abnormalities (defined as a summed stress
score 4 [23]), represented secondary perfusion outcomes.
ssessment of inflammatory biomarkers. Blood was
rawn in the morning prior to the PET scan after an overnight
ast. Plasma samples were separated and stored at80°C until
nalysis. We measured biomarkers of inflammation and endo-
helial cell activation, including C-reactive protein (CRP),
nterleukin (IL)-6, white blood cell count (WBC), and 2
oluble cell adhesion molecules, vascular cell adhesion molecule
VCAM)-1 and intercellular adhesion molecule (ICAM)-1.
RP was measured with the Beckman Coulter High Sensi-
ivity C-Reactive Protein assay on the Synchron LX-20 ana-
yzer (Beckman Coulter, Brea, California); the inter- and
ntra-assay precision of this test is5%. IL-6, VCAM-1, and
CAM-1 were assessed using commercially available ELISA
its from R and D Systems (Minneapolis, Minnesota). Inter-
nd intra-assay variability for these assays is 10%. WBC
ount was measured with the Beckman Coulter LH 750
ematology analyzer. All biochemical assays for each twin pair
Abbreviations
and Acronyms
CAD  coronary artery
disease
CFR  coronary flow
reserve
CRP  C-reactive protein
ICAM  intercellular
adhesion molecule
IL  interleukin
MBF  myocardial blood
flow
PET  positron emission
tomography
VCAM  vascular cell
adhesion molecule
WBC  white blood cell
countere processed in the same analytical run.
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Inflammation and Coronary Flow Reserve March 15, 2011:1271–9Other measurements. A medical history and a physical
exam were obtained from all twins. Concentrations of
glucose and plasma lipids were measured from overnight
fasting blood samples using standardized methods. Physical
activity was assessed with a modified version of the Baecke
Questionnaire of Habitual Physical Activity used in the
ARIC (Atherosclerosis Risk in Communities) study (24),
yielding a global score of physical activity at work, during
sports and nonsports activities.
Statistical analysis. CFR and inflammatory biomarkers
ere mainly analyzed as continuous variables; inflammatory
iomarker levels had a skewed distribution and were log
ransformed for analysis. All p values were corrected for the
orrelation between co-twins using generalized estimating
quations or mixed-effects models with a random intercept
or each pair, depending on variable distribution.
The association between inflammatory markers and mi-
rovascular dysfunction was first examined in the whole
ample of twins, treating twins as separate observations. In
hese analyses, all twins were examined regardless of
hether their brother was available for analysis, and CFR
as categorized according to quartiles. Next, we performed
omparisons within twin pairs, where inflammatory marker
evels were compared between brothers who differed in
FR. Within-pair differences in CFR were examined in 3
ays. First, we expressed the within-pair difference in CFR
s a continuous variable quantifying the individual twin
ariation from the twin pair average; this formulation is
nalogous to fitting the absolute difference between the
wins in a pair (25). Second, we simply classified each twin
s having either a higher or a lower CFR than his brother.
inally, we examined discordant twin pairs for a CFR2.5,
hich has been suggested as a cut point for microvascular
ysfunction, being the lower limit of normal flow reserve in
rteries free of obstructive CAD (26). The within-pair
ffects are inherently controlled for demographic, shared
amilial, and early environmental influences; in addition,
aily activities and other environmental factors during the
xamination day were controlled since twin pairs were
xamined together. Because twin pairs were raised together,
nd monozygotic pairs share 100% of their genetic material,
ny association between CFR and inflammatory markers
ithin monozygotic pairs cannot be ascribed to genes or
arly family environment such as parental influences, socio-
conomic status, and behaviors learned while growing up.
izygotic pairs also share familial factors, but on average,
nly share 50% of their genetic material. All analyses used
ixed effects regression models and accounted for the twin
air clustering by using a random effect term for each pair.
ecause the dependent variables were log transformed, and
he association was inverse, we expressed the results as
ercentage difference of the nontransformed values by using
he following formula: [1  (exp)]  100 (%); where  is
he regression coefficient and exp returns the exponentialvalue of the parameter.Because we were interested in microvascular dysfunction,
we adjusted for presence of perfusion abnormalities. Anal-
yses were further adjusted for factors that were significantly
different according to CFR status, or that were a priori
considered potentially important confounders, including
body mass index, previous history of CAD, study year, and
the Framingham risk score, which incorporates age, low-
density-lipoprotein cholesterol, high-density lipoprotein
cholesterol, blood pressure, diabetes mellitus, and smoking
(27). Sensitivity analyses were conducted by adjusting for
habitual physical activity (Baecke score), cardiac medica-
tions (statins, aspirin, beta-blockers, and angiotensin-
converting enzyme inhibitors), rate-pressure product during
the adenosine infusion, history of major depression (which
was a criterion for inclusion in a subsample), and by
adjusting for individual CAD risk factors rather than
including them in the Framingham risk score. We also
repeated the analyses after excluding a few individuals who
developed CAD between 1990 and the examination date.
All analyses were conducted using SAS software version 9.1
(SAS Institute, Cary, North Carolina). Significance level
was set at 0.05, 2-sided.
Results
Study sample. Of the 360 twins in THS, 57 were excluded
because of incomplete quantitative MBF data, and 35 were
excluded because of a previous history of CAD, leaving 268
twins in the analysis: 122 complete pairs (74 monozygotic
and 48 dizygotic) and 24 unpaired twins.
The mean CFR in the entire sample was 2.68, with a
standard deviation of 0.83. Within the 122 pairs, when each
twin was classified as having a higher or a lower CFR than
his brother, both twins had similar levels of risk factors,
medical history, and medication use, with the possible
exception of smoking (Table 1). The Framingham risk score
was also similar within pairs. The mean CFR was 3.11 in
the twins with higher CFR and 2.32 in their matched
brothers with lower CFR.
Imaging and hemodynamics. Less than 30% of the sample
had a summed stress score 4, which would indicate a
significant perfusion abnormality; this proportion was the
same comparing twins with higher and lower CFR within
pairs (Table 2). The overall perfusion defect score, either
during adenosine stress or at rest, was also similar, as were
hemodynamic responses during adenosine infusion, including
maximum systolic blood pressure, maximum heart rate, and
the average and maximum rate-pressure products (Table 2).
Inflammatory biomarkers and CFR. In the overall sam-
ple, inflammatory and endothelial activation biomarkers
showed a decreasing trend from the lowest to the highest
quartile of CFR, which was more pronounced for CRP,
IL-6, and WBC than for soluble cell adhesion molecules
(Fig. 1). Biomarker levels were expressed as geometric
means calculated from log-transformed data. Arithmetic
means show a larger spread of data; for example, for CRP,
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March 15, 2011:1271–9 Inflammation and Coronary Flow Reservethe arithmetic means going from the lowest to the highest
quartile of CFR were 6.10, 2.94, 2.95, and 1.58 mg/l.
The association was similar when CFR was analyzed as a
continuous variable, in the entire myocardium, and in
specific vascular territories (Table 3). For each unit of
increasing CFR in the entire myocardium, CRP decreased
17.0% (p  0.03), IL-6 decreased 14.5% (p  0.01), WBC
ecreased 4.5% (p  0.02), ICAM decreased 3.5% (p 
.08), and VCAM decreased 3.1% (p  0.22). All inflam-
atory biomarkers, except VCAM-1, were inversely associ-
ted with the CFR in all vascular territories. Although absolute
aximal flow was not significantly related to inflammation,
aximal flow increase from baseline showed similar relation-
hips: p  0.02 for CRP, p  0.003 for IL-6, p  0.005 for
BC, p  0.10 for ICAM, and p  0.30 for VCAM. In
ontrast, none of the biomarkers, except IL-6, were correlated
Within-Pair Comparison of Subject CharacteristiTable 1 Within-Pair Comparison of Subject C
Twin
Age, yrs 54
Systolic blood pressure, mm Hg 1
Diastolic blood pressure, mm Hg 81
LDL cholesterol, mg/dl 1
HDL cholesterol, mg/dl 38
Diabetes
Body mass index, kg/m2 28
Current smoker
Framingham Risk Score 5.
Physical activity (Baecke) score 7.
Number of alcoholic beverages in typical week 4.
Taking ACE inhibitors
Taking statins
Taking beta-blocker medications
Taking aspirin
Taking antidepressants
CFR 2.
All data are reported either as mean (95% confidence interval) or % of
or generalized estimating equations (GEE) for categorical variables. p
ACE  angiotensin-converting enzyme; CFR  coronary flow reserv
Within-Pair Comparison of MyocardialPerfusion Imaging Data According to CFR StatusTable 2 Within-Pair Comparison of Myoc rdialPerfusion Imaging Data According to CFR Status
Twin With
Lower CFR
(n  122)
Twin With
Higher CFR
(n  122) p Value
Abnormal perfusion (summed
stress score 4), n (%)
33 (27.3) 33 (27.3) 1.00
Summed stress score 2.75 (0.55) 2.50 (0.44) 0.66
Summed rest score 0.82 (0.28) 0.73 (0.21) 0.76
Summed difference score 1.93 (0.45) 1.77 (0.37) 0.77
Average rate-pressure product
during adenosine
92.5 (2.4) 88.4 (2.1) 0.12
Maximal rate-pressure
product during adenosine
115 (3) 110 (3) 0.16
Unless otherwise indicated, all data are reported as mean (SE) values. p values are obtained from
mixed models for continuous variables or generalized estimating equations for categoricalt
variables, including a random effect for pair.
CFR  coronary flow reserve.ith detectable myocardial perfusion abnormalities as mea-
ured by the summed stress score (data not shown).
Within pairs, all inflammatory biomarkers were higher in
he twins with lower CFR than in their siblings with higher
FR (Table 4). Of 122 complete twin pairs, 50 pairs were
iscordant, for a CFR of 2.5. Values of all biomarkers
xcept VCAM-1 were significantly higher in twins with a
FR 2.5 than their brothers with a CFR of 2.5 or higher.
or example, CRP was 65% higher and IL-6 was 54%
igher in the twin with CFR 2.5 than in his brother with
FR 2.5. These associations remained statistically signif-
cant and fundamentally unchanged after adjusting for the
ramingham risk score, body mass index, and summed
tress score (Table 5). Adjustment for education, marital
tatus, habitual physical activity, rate-pressure product dur-
ng the adenosine infusion, medications (statins, beta-
lockers, aspirin), and history of major depression did not
aterially change the results. Adjusting for individual risk
actors, rather than including them in the Framingham risk
core, also did not substantially change the results. Re-
ults were similar after stratification by zygosity, indicating
hat genetic factors do not play an important role in this
ssociation.
Results were also similar when subjects with significant
erfusion abnormalities (a summed stress score 4) were
xcluded. These results indicate that global myocardial
erfusion, rather than perfusion in specific coronary terri-
ories, was reduced in twins with higher inflammation.
iscussion
sing PET myocardial perfusion imaging in a sample of
cording to CFR Statuscteristics According to CFR Status
Lower CFR
122)
Twin With Higher CFR
(n  122) p Value
.5–54.6) 54.0 (53.5–54.6) —
6–132) 130 (127–132) 0.74
.2–83.2) 80.6 (78.7–82.6) 0.59
8–130) 127 (121–133) 0.44
.1–40.3) 39.6 (37.8–41.4) 0.32
.20 8.26 0.99
.0–29.6) 29.2 (28.4–30.0) 0.34
.9 15.6 0.10
39–6.14) 5.70 (5.31–6.09) 0.76
02–7.70) 7.45 (7.15–7.74) 0.67
27–6.32) 5.49 (3.51–7.48) 0.58
.7 9.84 0.83
.1 17.2 0.24
.92 4.10 0.71
.4 19.7 0.51
.4 12.3 0.35
21–2.42) 3.11 (2.95–3.26) 0.001
ts. p values are obtained from mixed models for continuous variables
for inflammatory biomarkers are based on log-transformed data.
 high-density lipoprotein; LDL  low-density lipoprotein.cs Achara
With
(n 
.0 (53
30 (12
.2 (79
24 (11
.7 (37
8
.8 (28
22
76 (5.
36 (7.
79 (3.
10
22
4
16
16
32 (2.
subjecwins without symptomatic CAD, we found a robust
1276 Vaccarino et al. JACC Vol. 57, No. 11, 2011
Inflammation and Coronary Flow Reserve March 15, 2011:1271–9association linking biomarkers of systemic inflammation
and endothelial cell activation with lower CFR. We also
found that this association is independent of CAD risk
factors, as well as of familial and genetic factors shared by
the twins. In addition, the relationship was independent of
perfusion defects, suggesting that the microvascular circu-
lation plays a role. Although no direct causality can be
inferred from our data, our results are suggestive of a
mechanistic relationship between inflammation and micro-
vascular function and highlight the importance of inflam-
matory processes in the early phases of CAD.
The role of inflammation in the pathogenesis of athero-
sclerosis has been widely recognized for many years (28,29).
In addition to extensive experimental research, clinical
studies have found a link between peripheral vascular
function and inflammation (5,6). However, data from the
peripheral circulation cannot necessarily be extrapolated to
the coronary circulation (30), for which much less is known.
Two studies found an attenuated CFR in patients with
Figure 1 Geometric Means of Inflammatory Biomarkers Accord
Quartile ranges: quartile 1: coronary flow reserve (CFR) 3.04 to 6.84; quartile 2: C
refer to tests for trend. CRP  C-reactive protein; ICAM  intercellular adhesion m
blood cell count.
Percentage Decrease in Inflammatory Biomarkers per 1-U IncreaseTable 3 Percentage Decrease in Infla matory Biomarkers per
Entire Myocardium Left Anterior D
% p Value %
CRP, mg/l 17.0 0.03 16.6
IL-6, pg/dl 14.5 0.01 13.6
WBC, 1,000/l 4.5 0.02 4.7
ICAM-1, ng/ml 3.5 0.08 2.9
VCAM-1, ng/ml 3.1 0.22 2.5
Percentage decrease in biomarkers is per 1-U increase in coronary flow reserve (CFR), in the ent
log-transformed biomarker data. Percentages are calculated from regression coefficients.
CRP  C-reactive protein; ICAM  intercellular adhesion molecule; IL  interleukin; VCAM  vascularchronic inflammatory conditions, including rheumatoid ar-
thritis and systemic lupus erythematosus, but without sig-
nificant coronary stenosis, compared with controls (31,32).
However, 2 additional studies of patients with chest pain
and no obstructive CAD were not able to demonstrate a
relationship between invasive angiographic assessment of
CFR and levels of inflammatory biomarkers (7,8); although,
in 1 of these, endothelial function measured with adminis-
tration of intracoronary acetylcholine was correlated with
CRP (7). These contrasting findings may be due to selected
study samples that included symptomatic patients referred
for medical evaluation, and/or inadequacies in the selection
of control groups. No previous investigation explored the
relationship between inflammation and CFR in asymptom-
atic individuals from the community.
A link between inflammation and coronary microvascular
function may result from early atherosclerotic changes,
microvascular endothelial or smooth muscle dysfunction,
and/or inflammation of the coronary microvasculature.
o Quartiles of CFR
9 to 3.03; quartile 3: CFR 2.10 to 2.58; quartile 4: CFR 1.06 to 2.09. p values
e; IL  interleukin; VCAM  vascular cell adhesion molecule; WBC  white
FRncrease in CFR
ing Circumflex Right Coronary Artery
alue % p Value % p Value
3 18.5 0.009 15.4 0.05
08 16.1 0.001 13.3 0.01
1 4.3 0.01 4.5 0.02
2 2.5 0.17 2.7 0.16
7 1.5 0.48 2.4 0.31
cardium, and in regional coronary artery territories. Values are derived from mixed models withing t
FR 2.5
oleculin C1-U I
escend
P V
0.0
0.0
0.0
0.1
0.2
ire myocell adhesion molecule; WBC  white blood cell count.
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March 15, 2011:1271–9 Inflammation and Coronary Flow ReserveAdenosine-induced hyperemic response incorporates both
endothelium-dependent and endothelium-independent
pathways (33). Endothelium-derived nitric oxide is a key
modulator of vascular tone and plays an important role in
the regulation of the coronary microcirculation (34). Inhi-
bition of the endothelial nitric oxide synthase by intravenous
infusion of L-NG-monomethyl arginine reduces the vaso-
dilatory response to adenosine by about 25% as measured by
PET, suggesting a role of the endothelium (35,36). Al-
though the influence of inflammatory processes on coronary
microvascular physiology and pathology has been less stud-
ied, our study suggests that similar processes are involved.
Increased inflammation in the artery wall may result from
oxidative stress due to reduced endothelium-derived nitric
oxide. For example, oxidative stress is critical for the
activation of nuclear factor-kappa B (NF-B) (37), a tran-
cription factor that increases the expression of pro-
nflammatory cytokines, chemokines, and cell adhesion
olecules through angiotensin-II stimulation. Increased
nflammation may also reflect injury of the arterial wall in
he early phases of the atherosclerotic process (33).
Although our study subjects were asymptomatic and
ithout a prior history of CAD, 27% of them showed
erfusion defects by PET imaging. This relatively high
revalence of perfusion abnormalities is not surprising given
hat CAD risk factors, such as smoking, obesity, and
ypertension, were common in this sample. The prevalence
Unadjusted Within-Pair Differences in Plasma Inflammatory BiomarTable 4 Unadjusted Within-Pair Differences in Plasma Infla ma
Inflammatory Markers
(n  122 Twin Pairs)
Twin With
Lower CFR
Twin With
Higher CFR
Within-Pair
Difference (%)
CRP, mg/l 1.40 (1.11) 1.10 (1.12) 21.0
IL-6, pg/dl 2.04 (1.07) 1.65 (1.07) 18.7
WBC, 1,000/l 6.35 (1.02) 5.87 (1.02) 7.5
ICAM-1, ng/ml 323 (1.02) 302 (1.02) 6.6
VCAM-1, ng/ml 614 (1.03) 573 (1.03) 6.7
Values are geometric mean (SE) unless otherwise indicated. CFR is defined as the ratio of myocard
random intercept for pair.
Abbreviations as in Table 3.
Adjusted Within-Pair Differences in Plasma Inflammatory BiomarkeTable 5 Adjusted Within-Pair Differences in Plasma Infla mato
Inflammatory Markers
(n  122 Twin Pairs)
Twin With
Lower CFR
Twin With
Higher CFR
Within-Pair
Difference (%)
CRP, mg/l 1.42 (1.10) 1.11 (1.10) 22.2
IL-6, pg/dl 2.05 (1.07) 1.65 (1.07) 19.4
WBC, 1,000/l 6.38 (1.02) 5.89 (1.02) 7.6
ICAM-1, ng/ml 322 (1.02) 301 (1.02) 6.5
VCAM-1, ng/ml 610 (1.03) 570 (1.03) 6.6
Values are geometric mean (SE) unless otherwise indicated. CFR is defined as the ratio of myocard
random intercept for pair. All estimates adjusted for perfusion defect score, Framingham risk score
body mass index, and study year. Adjusting for additional covariables, including education, marita
(statins, beta-blockers, aspirin), did not materially change the results.
Abbreviations as in Tables 1 and 3.f myocardial perfusion abnormalities in asymptomatic
ubjects at risk (either because of family history or because of
isk factors) has been reported to be between 20% and
0% (38 – 40). Therefore, our data are consistent with
revious published reports. These perfusion abnormali-
ies may be due to pre-clinical, mild, or diffuse coronary
rtery narrowing, or to endothelial dysfunction preceding
uminal narrowing. Indeed, adenosine-induced hyper-
mia is a mixture of both endothelial-dependent and
independent pathways (33).
In contrast to their robust relationship with CFR, none of
he inflammatory biomarkers, except IL-6, were associated
ith perfusion defects. These results clearly demonstrate
hat the link between inflammation and CFR in our study
as driven by microvascular dysfunction rather than epicar-
ial coronary stenoses. The association, however, could be
n epiphenomenon of risk factors such as hypercholesterol-
mia, hypertension, diabetes, and smoking, which have been
inked to perfusion abnormalities even in the absence of
oronary obstruction (10–15). We were able to demonstrate
hat CAD risk factors did not explain the link between
icrovascular function and inflammation. As a whole, our
ata highlight the importance of inflammation in the early
hases of the atherosclerotic process in asymptomatic indi-
iduals, because microvascular dysfunction appears to pre-
ede the development of frank CAD (41). These results
ay also have implications for prevention, since microvas-
evels Based on CFR Discordance StatusBiomarker Levels Based on CFR Discordance Status
Inflammatory Markers
(n  50 Twin Pairs)
Value
Twin With
CFR <2.5
Twin With
CFR >2.5
Within-Pair
Difference (%) p Value
0.04 1.67 (1.18) 1.01 (1.18) 65.4 0.006
0.02 2.65 (1.11) 1.72 (1.11) 54.2 0.002
0.005 6.44 (1.04) 5.89 (1.04) 9.3 0.04
0.02 336 (1.04) 303 (1.04) 11.0 0.02
0.04 603 (1.05) 580 (1.05) 4.0 0.46
d flow during adenosine to flow at baseline. All values in table are derived frommixed models with
els Based on CFR Discordance Statusomarker Levels Based on CFR Discordance Status
Inflammatory Markers
(n  50 Twin Pairs)
Value
Twin With
CFR <2.5
Twin With
CFR >2.5
Within-Pair
Difference (%) p Value
0.03 1.77 (1.17) 1.09 (1.17) 62.9 0.006
0.02 2.63 (1.11) 1.74 (1.11) 51.2 0.003
0.003 6.42 (1.04) 5.94 (1.04) 8.2 0.06
0.02 332 (1.04) 302 (1.04) 9.7 0.04
0.049 605 (1.05) 580 (1.05) 4.3 0.44
d flow during adenosine to flow at baseline. All values in table are derived frommixed models with
ing age, current smoking, systolic blood pressure, LDL cholesterol, HDL cholesterol, and diabetes),
, habitual physical activity, rate-pressure product during the adenosine infusion, and medicationsker Ltory
p
ial bloor Levry Bi
p
ial bloo
(includ
l status
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Inflammation and Coronary Flow Reserve March 15, 2011:1271–9cular dysfunction is potentially reversible and is associated
with future cardiovascular events (16,17).
Study limitations. Our study is cross-sectional, thus lim-
ited in the ability to discern the temporal order between
inflammation and CFR. Furthermore, as in any study,
sample variability in biomarker assays may increase random
error. However, all assays used in this study have acceptable
levels of precision. Nonetheless, it is possible that the lack of
significant findings for ICAM- and VCAM-1 is in part due
to random error. Because our twins were all middle-aged
male military veterans, caution should be used in general-
izing our results to women or to younger or older individ-
uals. On the other hand, using a co-twin design, we were
able to control for many unmeasured risk factors including
maternal factors, early familial environment, and genetic
influences, in addition to a comprehensive set of measured
CAD risk factors. Finally, CFR measurement based on
nitrogen 13 [13N] ammonia PET perfusion imaging is
currently limited to institutions with onsite cyclotrons,
which may limit clinical utility. It is likely that new methods
will allow the measurement of MBF using agents that do
not require a cyclotron in the near future. Until these
techniques become available, PET with 13N remains the
gold standard method for the noninvasive assessment of
CFR.
Conclusions
We found that in asymptomatic middle-aged subjects, a
decrease in coronary microvascular function is associated
with increased systemic inflammatory response. Given the
demonstrated importance of inflammation in the pathogen-
esis of CAD, our results, using a controlled design of
matched twin pairs, support the pathogenic role of inflam-
mation in human microvascular dysfunction.
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